The vanilloid receptor and hypertension

Acta Pharmacologica Sinica

Volumn 26, Issue 3, 2005, Pages 286-294

  Wang, Donna H ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Afferent neurons; Calcitonin gene related peptide; Capsaicin; Endothelin, sympathetic nervous system; Renin angiotensin aldosterone system; Salt sensitive hypertension; Substance P; TRP family; Vanilloid receptor

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; ENDOTHELIN 1 RECEPTOR; ENDOTHELIN RECEPTOR; NATRIURETIC FACTOR; SODIUM CHLORIDE; SUBSTANCE P; TRANSIENT RECEPTOR POTENTIAL CHANNEL; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; VASODILATOR AGENT;

ADRENERGIC SYSTEM; ALDOSTERONE BLOOD LEVEL; BINDING SITE; BLOOD PRESSURE; CALCIUM TRANSPORT; EFFERENT NERVE; HYPERTENSION; NERVE CONDUCTION; NONHUMAN; PLASMA RENIN ACTIVITY; RECEPTOR BINDING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SALT LOADING; SENSORY NERVE; SODIUM TRANSPORT; SYMPATHETIC INNERVATION;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CAPSAICIN; HUMANS; HYPERTENSION; ION CHANNELS; NEURONS, AFFERENT; RECEPTORS, DRUG; RENIN-ANGIOTENSIN SYSTEM; SODIUM CHLORIDE, DIETARY; SUBSTANCE P; TRPV CATION CHANNELS;

EID: 15244349324     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2005.00057.x     Document Type: Review

References (82)

1. Clapham DE. TRP channels as cellular sensors. Nature 2003; 426: 517-24.
2. Nagy JI. Capsaicin: a chemical probe for sensory neuron mechanisms. In: Iversen LL, Iversen SD, Snyder SH, editors. Handbook of psychopharmacology; v 15. New York: Plenum Press; 1982. p 185-235.
3. Thresh LT. Isolation of capsaicin. Pharm J 1846; 6: 941.
4. Hogyes E. Beitrage zur physiologischen Wirkung der Bestandteile des Capsicum annuum. Arch Exp Pathol Pharmakol 1878; 9: 117-30
5. Nelson EK. The constitution of capsaicin, the pungent principal of capsicum. J Am Chem Soc 1919; 41: 1115-21.
6. Jancso N. Pharmacological analysis of the function and receptor structure of the pain-sensitive nerve endings. Acta Physiol Hung 1957; 11 (Suppl); 11-4.
7. Bevan S, Szolcsanyi J. Sensory neuron-specific actions of capsaicin: mechanisms and applications. Trends Pharmacol Sci 1990; 11: 330-3.
8. Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for sensory neurons. Pharmacol Rev 1991; 43: 143-201.
9. Szolcsanyi J, Porszasz R, Petho G. Capsaicin and pharmacology of nociceptors. In: Besson JM, editor. Peripheral neurons in nociception: physio-pharmacological aspects. Paris: John Libbey; 1994. p 109-24.
10. Fitzgerald M. Capsaicin and sensory neurons: a review. Pain 1983; 15: 109-30.
11. Maggi CA, Meli A. The sensory-efferent function of capsaicin-sensitive neurons. Gen Pharmacol 1988; 19: 1-43.
12. Nagy JI. Capsaicin's action on the nervous system. Trends Neurosci 1982; 5: 362-5.
13. Szolcsanyi J. Forty years in capsaicin research for sensory pharmacology and physiology. Neuropeptides 2004; 38: 377-84.
14. Virus RR, Gebhart GF. Pharmacologic actions of capsaicin: apparent involvements of substance P and serotonin. Life Sci 1979; 25: 1273-84.
15. Maggi CA. The pharmacological modulation of neurotransmitter release. In: Wood John, editor. Capsaicin in the study of pain. New York: Harcourt Brace & Company; 1993. p 161-89.
16. Lindsay RM, Lockett C, Sternbeg J, Winter J. Neuropeptide expression in cultures of adult sensory neurons: modulation of substance P and calcitonin gene-related peptide levels by nerve growth factor. Neuroscience 1989; 33: 53-65.
17. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide, and other neuropeptides. Neuroscience 1988; 24: 739-68.
18. Kawasaki H, Nuki C, Saito A, Takasaki K. Adrenergic modulation of calcitonin gene-related peptide (CGRP) containing nerve-mediated vasodilation in the rat mesenteric resistance vessel. Brain Res 1990; 506: 287-90.
19. 2 enhances bradykinin stimulated release of neuropeptides from rat sensory neurons in culture. J Neurosci 1994; 14: 4987-97.
20. Dymshitz J, Vasko MR. Endothelin-1 enhances capsaicin-induced peptide release and cGMP accumulation in cultures of rat sensory neurons. Neurosci Lett 1994; 167: 128-32.
21. 1 Winter J, Dray A, Wood JN, Yeats JC, Bevan S. Cellular mechanism of action of resiniferatoxin: a potent sensory neuron excitotoxin. Brain Res 1990; 520: 13-40.
22. Bevan S, Forbes CA. Membrane effects of capsaicin on rat dorsal root ganglion neurons in culture. J Physiol 1988; 398: 28.
23. Forbes CA, Bevan S. Single channels activated by capsaicin in patches of membrane from adult rat sensory neurons in culture. Neurosci Lett 1998; S3: 32.
24. Marsh SJ, Stansfeld CE, Brown DA, Davey R, McCarthy D. The mechanism of action of capsaicin on sensory C-type neurons and their axons in vitro. Neuroscience 1987; 23: 275-89.
25. Wood JN, Winter J, James IF, Rang HP, Yeats J, Bevan S. Capsaicin-induced ion fluxes in dorsal root ganglion cells in culture. J Neurosci 1988; 8: 3208-20.
26. Szolcsanyi J, Jancso-Gabor A. Sensory effects of capsaicin congeners. I. Relationship between chemical structure and pain-producing potency of pungent agents. Drug Res 1975; 25: 1877-81.
27. Szolcsanyi J, Jancso-Gabor A. Sensory effects of capsaicin congeners. II. Importance of chemical structure and pungency in desensitizing activity of capsaicin-like compounds. Drug Res 1976; 26: 33-7.
28. deVries DJ, Blumberg PM. Thermoregulatory effects of resiniferatoxin in the mouse: comparison with capsaicin. Life Sci 1989; 44: 711-5.
29. Szallasi A, Blumberg PM. Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper. Neuroscience 1989; 30: 515-20.
30. Winter J, Dray A, Wood JN, Yeats JC, Bevan S. Cellular mechanism of action of resiniferatoxin: a potent sensory neuron excitotoxin. Brain Res 1990; 520: 131-40.
31. Bevan S, Hothi S, Hughes G, James IF, Rang HP, Shah K, et al. Capsazepine: a competitive antagonist of the sensory neuron excitant capsaicin. Br J Pharmacol 1992; 107: 544-52.
32. Caterina MJ, Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu Rev Neurosci 2001; 24: 487-517.
33. Hua XY, Lundberg JM. Dual capsaicin effects on ureteric motility: low dose inhibition mediated by CGRP and high dose stimulation by tachykinins? Acta Physiol Scand 1986; 128: 453-65.
34. Bell D, McDermott B. Calcitonin gene-related peptide in the cardiovascular system: characterization of receptor populations and their (patho)physiological significance. Pharmacol Rev 1996; 48: 257.
35. Buck SH, Burks TF. The neuropharmacology of capsaicin: review of some recent observations. Pharmacol Rev 1986; 38: 179-226.
36. Jancso G, Kiraly E, Jancso-Gabor A. Pharmacologically induced selective degeneration of chemosensitive primary sensory neurons. Nature 1977; 270: 741-3.
37. Lawson SN, Nickels SM. The use of morphometric techniques to analyze the effect of neonatal capsaicin treatment on rat dorsal root ganglia and dorsal roots. J Physiol 1980; 303: 12.
38. Scadding JW. The permanent anatomical effects of neonatal capsaicin on somatosensory nerves. J Anat 1980; 131: 471-82.
39. Nagy JI, Iversen LL, Goedert M, Chapman D, Hunt SP. Dose-dependent effects of capsaicin on primary sensory neurons in the neonatal rat. J Neurosci 1983; 3: 399-406.
40. Jancso G, Karcsu S, Kiraly E, Szebeni A, Toth L, Bacsy E, et al. Neurotoxin induced nerve cell degeneration: possible involvement of calcium. Brain Res 1984; 295: 211-6.
41. Nagi JI, Hunt SP, Iversen LL, Emson PC. Biochemical and anatomical observations on the degeneration of peptide-containing primary afferent neurons after neonatal capsaicin. Neuroscience 1981; 6: 1923-34.
42. Breimer LH, MacIntyre I, Zaidi M. Peptides from the calcitonin genes: molecular genetics, structure, and function. Biochem J 1988; 255: 377-90.
43. Wimalawansa SJ. Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials. Endocr Rev 1996; 17: 533-85.
44. Preibisz JJ. CGRP and regulation of human cardiovascular homeostasis. Am J Hypertens 1993; 6: 434-50.
45. Zaidi M, Moonga BS, Bevis PJ, Bascal ZA, Breimer LH. The calcitonin gene peptides: biology and clinical relevance. Crit Rev Clin Lab Sci 1999; 28: 109.
46. McEwan J, Legon S, Wimalawansa SJ, Zaida M, Dollery CT, MacIntyre I. Calcitonin gene-related peptide: a review of its biology and relevance to the cardiovascular system. In: Laragh JH, Brenner BN, Kaplan NM, editors. Endocrine mechanisms in hypertension. New York: Raven Press; 1989. p 287.
47. Asimakis GK, DiPette DJ, Conti VR, Holland OB, Zwischenberger JB. Hemodynamic action of calcitonin gene-related peptide in the isolated rat heart. Life Sci 1987; 41: 597.
48. DiPette DJ, Scwarzenberger K, Kerr N, Holland OB. Dose-dependent systemic and regional hemodynamic effects of calcitonin gene-related peptide. Am J Med Sci 1989; 297: 65.
49. Supowit SC, Zhao H, Hallman DM, DiPette DJ. Calcitonin gene-related peptide is a depressor of deoxycorticosterone-salt hyperten-sion. Hypertension 1997; 29: 945-50.
50. Burg M, Zahm DS, Knuepfer MM. Intrathecal capsaicin enhances one-kidney renal wrap hypertension in the rat. J Auton Nerv Syst 1994; 50: 180-99.
51. Manzini S, Bacciarelli C. Enhanced development of deoxycorticosterone- induced hypertension in neonatally capsaicin-pretreated rats. Regul Pept 1988; 22: 119.
52. Wang DH, Li J, Qiu J. Salt-sensitive hypertension induced by sensory denervation: introduction of a new model. Hypertension 1998; 32: 649-53.
53. Wang DH, Li J. Antihypertensive mechanisms underlying a novel salt-sensitive hypertensive model induced by sensory denervation. Hypertension 1999; 33: 499-503.
54. Huang Y, Wang DH. Role of AT1 and AT2 receptor subtypes in salt-sensitive hypertension induced by sensory nerve degeneration. J Hypertens 2001; 19: 1841-6.
55. Huang Y, Wang DH. Role of renin-angiotensin-aldosterone system in salt-sensitive hypertension induced by sensory denervation. Am J Physiol Heart Circ Physiol 2001; 281: H2143-9.
56. Wu W, Zhang Y, Ballew JR, Fink G, Wang DH. Development of hypertension induced by subpressor infusion of angiotensin II. Hypertension 2000; 36: 549.
57. Wang DH, Wu W, Lookingland KJ. Degeneration of capsaicin-sensitive sensory nerves leads to increased salt sensitivity through enhancement of sympathoexcitatory response. Hypertension 2001; 37: 440-3.
58. Lefevre-Borg F, Roach AG, Gomeni R, Cavero I. Mechanism of antihypertensive therapy of orally administered prazosin in spontaneously hypertensive rats. J Cardiovasc Pharmacol 1979; 1: 31-42.
59. Osborn JW, Provo BJ, Montana JS III, Trostel KA. Salt-sensitive hypertension caused by long-term α-adrenergic blockade in the rat. Hypertension 1993; 21: 995-9.
60. Ye DZ, Wang DH. Function and regulation of endothelin-1 and its receptors in salt sensitive hypertension induced by sensory nerve degeneration. Hypertension 2002; 39: 673.
61. Dohi Y, Hahn AW, Boulanger CM, Buhler FR, Luscher TF. Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension 1992; 19: 131-7.
62. Imai T, Hirata Y, Emori T, Yanagisawa M, Masaki T, Marumo F. Induction of endothelin-1 gene by angiotensin and vasopressin in endothelial cells. Hypertension 1992; 19: 752-7.
63. A-receptor antagonist. Circulation 1997; 96: 1593-7.
64. Loffler BM, Breu V, Clozel M. Effect of different endothelin receptor antagonists and of the novel non-peptide antagonist R046-2005 on endothelin levels in rat plasma. FEBS Lett 1993; 333: 108-10.
65. B receptor in rats. Biochem Biophys Res Commun 1994; 199: 1461-5.
66. Tjen-A-Looi S, Kraiczi H, Ekman R. Keith IM. Sensory CGRP depletion by capsaicin exacerbates hypoxia-induced pulmonary hypertension in rats. Regul Pept 1998; 74: 1-10.
67. Zhou KR, Lai YL. Capsaicin pretreatment attenuates monocrotaline-induced ventilatory dysfunction and pulmonary hypertension. J Appl Physiol 1993; 75: 2781-8.
68. Szallasi A. Vanniloid receptor ligands: hopes and realities for the future. Drugs Aging 2001; 18: 561-73.
69. Li J, Kaminski NE, Wang DH. Anandamide-induced depressor effect in spontaneously hypertensive rats: role of the vanilloid receptor. Hypertension 2003; 41 (3 Pt 2): 757-62.
70. De Petrocellis L, Bisogno T, Maccarrone M, Davis JB, Finazzi-Agro A, Di Marzo V. The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J Biol Chem 2001; 276: 12856-63.
71. Smart D, Gunthorpe MJ, Jerman JC, Nasir S, Gray J, Miur AI, et al. The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). Br J Pharmacol 2000; 129: 227-30.
72. Zygmunt PM, Petersson J, Andersson DA, Chuang H, Sorgard M, Di Marzo V, et al. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 1999; 400: 452-7.
73. Zygmunt PM, Chuang H, Movahed P, Julius D, Hogestatt ED. The anandamide transport inhibitor AM404 activates vanilloid receptors. Eur J Pharmacol 2000; 396: 39-42.
74. Malinowska B, Kwolek G, Gothert M. Anandamide and methanandamide induce both vanilloid VR1- and cannabinoid CB1 receptor-mediated changes in heart rate and blood pressure in anesthetized rats. Naunyn Schmiedebergs Arch Pharmacol 2001; 364: 562-9.
75. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992; 258: 1946-9.
76. Feuerstein G, Willette R, Aiyar N. Clinical perspectives of calcitonin gene-related peptide pharmacology. Can J Physiol Pharmacol 1995; 73: 1070-4.
77. Edvinsson L, Fredholm BB, Hamel E, Jansen I, Verrecchia C. Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium derived relaxing factor. Neurosci Lett 1985; 58: 213-7.
78. European CGRP in Subarachnoid Hemorrhage Study Group. Effects of calcitonin gene-related peptide in patients with delayed post-operative cerebral ischemia after aneurysmal subarachnoid hemorrhage. Lancet 1992; 339: 831-3.
79. Gennari C, Nami R, Agnusdei D. Improved cardiac performance with human calcitonin gene-related peptide in patients with congestive heart failure. Cardiovasc Res 1990; 24: 239-41.
80. Shekhar YC, Anard IS, Sarma R, Ferrari R, Wahi PL, Poole-Wilson PA. Effects of prolonged infusion of human alpha CGRP on hemodynamics, renal blood flow, and hormone levels in congestive heart failure. Am J Cardiol 1991; 67: 732-8.
81. Uren NG, Seydoux D, Davies GJ. Effect of intravenous calcitonin gene-related peptide on ischaemia threshold and coronary stenosis severity in humans. Cardiovasc Res 1993; 27: 1477-81.
82. Shawket S, Dickerson C, Haxleman B, Brown MJ. Prolonged effect of CGRP in Raynaud's patients: a double blind randomized comparison with prostacyclin. Br J Clin Pharmacol 1991; 32: 209-13.